Acceleron Pharmaincis A Clinical Stagebiopharmaceutical Company Located In Cambridgemassachusettsfounded In 200 Thecompany Focuses On Developing Medicines That Target Thetransforming Growth Factor Betatgf I Superfamily Of Proteinswhich Areessential For Cell And Tissuegrowth And Repair Thecompany Specializes In Creating Drugs For Significant Unmet Medical Needsutilizing Proprietary Methods To Harness Thetherapeutic Potential Of Growth And Differentiation Factorsits Pipelineincludes Several Drug Candidates Currently In Clinical Trialssuch As Luspatercept For Anemiasotatercept For Pulmonary Arterial Hypertensiondalantercept For Kidney Cancerand Ace08 For Muscular Disordersacceleron Pharma Is Also Working On Treatments For Myelofibrosis And Fibrosisas A Subsidiary Of Merck & Co Acceleron Benefits From A Strong Partnership In Thepharmaceutical Industry
